$8.10
0.172.14%
At Close: -
$8.08
-0.02-0.25%
After Hours: Aug 23, 5:10 PM EDT
15 minutes delayed
BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.06 | $-0.17 | 64.7 % |
Mar 2024 | 2024-05-06 | $-0.17 | $-0.21 | 19.1 % |
Dec 2023 | 2024-02-26 | $-0.28 | $-0.24 | -16.7 % |
Sep 2023 | 2023-11-02 | $-0.19 | $-0.23 | 17.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $109.33M | $98.47M | 11.0 % |
Mar 2024 | 2024-05-06 | $92.76M | $85.60M | 8.37 % |
Dec 2023 | 2024-02-26 | $93.40M | $90.01M | 3.77 % |
Sep 2023 | 2023-11-02 | $86.74M | $85.95M | 0.92 % |
BioCryst Pharma (BCRX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.06, which beat the estimate of $-0.17.
The Actual Revenue was $109.3M, which beat the estimate of $98.5M.
Browse earnings estimates, EPS, and revenue on all stocks.